Device type · MBX
Stimulator, Thalamic, Epilepsy, Implanted
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MBX
Neurology
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
98
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Stimulator, Thalamic, Epilepsy, Implanted
- Product code
- MBX
- Device class
- Class III
- Review panel
- Neurology
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for MBX
Latest FDA decisions
- MEDTRONIC DBS THERAPY FOR EPILEPSYPMA supplement
P960009-S219 · Decided Apr 27, 2018 · 1,158 days after receipt · Panel Track
Device type: Stimulator, thalamic, epilepsy, implanted (MBX) · Neurology & Neurosurgery
Reports received
98
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
56
57% of reports
Injury reports
42
43% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 3 | 1 | 0 | 0 |
| Feb 24 | 9 | 2 | 0 | 0 |
| Mar 24 | 2 | 1 | 0 | 0 |
| Apr 24 | 1 | 1 | 0 | 0 |
| May 24 | 7 | 3 | 0 | 0 |
| Jun 24 | 0 | 1 | 0 | 0 |
| Jul 24 | 2 | 6 | 0 | 0 |
| Aug 24 | 7 | 3 | 0 | 0 |
| Sep 24 | 3 | 1 | 0 | 0 |
| Oct 24 | 1 | 4 | 1 | 0 |
| Nov 24 | 0 | 4 | 0 | 0 |
| Dec 24 | 7 | 2 | 0 | 0 |
| Jan 25 | 8 | 2 | 0 | 0 |
| Feb 25 | 3 | 3 | 0 | 0 |
| Mar 25 | 7 | 4 | 0 | 0 |
| Apr 25 | 5 | 1 | 0 | 0 |
| May 25 | 6 | 1 | 0 | 0 |
| Jun 25 | 1 | 2 | 0 | 0 |
| Jul 25 | 5 | 5 | 0 | 0 |
| Aug 25 | 2 | 1 | 0 | 0 |
| Sep 25 | 3 | 1 | 0 | 0 |
| Oct 25 | 9 | 0 | 0 | 0 |
| Nov 25 | 4 | 3 | 0 | 0 |
| Dec 25 | 5 | 2 | 0 | 0 |
| Jan 26 | 3 | 4 | 0 | 0 |
| Feb 26 | 4 | 0 | 0 | 0 |
| Mar 26 | 3 | 4 | 0 | 0 |
| Apr 26 | 10 | 1 | 0 | 0 |
| May 26 | 2 | 3 | 0 | 0 |
| Jun 26 | 3 | 3 | 0 | 0 |
| Jul 26 | 4 | 3 | 0 | 0 |
| Aug 26 | 6 | 7 | 0 | 0 |
| Sep 26 | 5 | 8 | 0 | 0 |
| Oct 26 | 7 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem17
- High impedance16
- Failure to Deliver Energy14
- Insufficient Device Problem Information13
- Battery Problem8
- Patient Device Interaction Problem8
- Therapeutic or Diagnostic Output Failure7
- Break6
- Charging Problem6
- Communication or Transmission Problem6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions48
- Convulsion/Seizure22
- Insufficient Information13
- Unspecified Infection7
- Cognitive Changes6
- Electric Shock6
- Discomfort4
- Intracranial Hemorrhage4
- Burning Sensation3
- Pain3
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls for this product code in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.